[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BadInvestor9 @badinvestor99 on x XXX followers
Created: 2025-07-25 20:20:02 UTC
@bioinvestor24 @Matthew_ABCD You realize <20% of NASH patients respond to GLP1. XX% of patients experience weight loss however. The two are mostly unrelated. Treatments follow steps it’s not one size fits all. $akro has the highest fibrosis benefit but the lowest weight loss.
XXX engagements
Related Topics $akro weight loss